Skip to main content
. 2017 Nov 7;23(41):7397–7406. doi: 10.3748/wjg.v23.i41.7397

Table 3.

Baseline characteristics comparison between anastomotic and non-anastomotic strictures n (%)

Characteristic Anastomotic strictures (n = 43) Non-anastomotic strictures (n = 37) P value
Female/male (n) 19/24 22/15 0.173
Disease duration in years (median; min-max) 19.2 (5.7-52.1) 16.3 (3.0-45.3) 0.236
Follow-up since 1st dilation in years (median; min-max) 4.4 (1.3-6.8) 2.9 (1.2-6.5) < 0.001
Time between 1st and 2nd dilation in days (median; min-max) 453.5 (152-1362) 368 (157-1705) 0.796
Age at index colonoscopy (mean; standard deviation) 44.9 (± 12.2) 39 (± 12.2) 0.035
Montreal classification
Age at diagnosis 0.368
A1 6 (14) 4 (12.9)
A2 29 (67.4) 25 (80.6)
A3 8 (18.6) 2 (6.5)
Disease location 0.057
L1 23 (53.5) 9 (29)
L2 1 (2.3) 4 (12.9)
L3 17 (39.5%) 14 (45.2%)
L1-4 2 (4.7%) 3 (9.7%)
L3-4 - 1 (3.2%)
Behavior
B1 1 (2.3) 4 (12.9) 0.071
B2 22 (51.2) 19 (61.3) 0.387
B3 20 (46.5) 8 (25.8) 0.07
Perianal disease 12 (27.9) 9 (29) 0.916
Smoking habits 0.635
Non-smoker 22 (52.4) 11 (44)
Ex-smoker 8 (19) 9 (36)
Current smoker 12 (28.6) 5 (20)
Medication at index colonoscopy
Thiopurines 23 (53.5) 25 (67.6) 0.200
Anti-TNFα 17 (39.5) 19 (51.4) 0.289
Obstructive symptoms 15 (35.7) 10 (27.8) 0.454
C-reactive protein 2.8 (0.3-18.4) 6.95 (0.2-35.5) 0.126
Calprotectin 103.5 (5.9-1356) 283 (166-321) 0.789
Lactoferrin 7.66 (1.05-204.4) 10.7 (7.1-22.7) 0.429
Need to repeat dilation 27 (62.8) 15 (40.5) 0.047

TNFα: Tumor necrosis factor α.